Diamyd, an alum-formulated recombinant human GAD65 for the prevention of autoimmune diabetes
{{output}}
Diamyd Medical AB is developing Diamyd (GAD-65), an alum formulation of a full-length recombinant human glutamic acid decarboxylase 65 for subcutaneous injection, for the potential prevention and treatment of type 1 diabetes (T1DM) or latent autoimmune diabete... ...
